A method is proposed to reduce portal hypertension utilizing subtotal splenectomy and a central splenorenal shunt. The advantages of this method are: diversion of the splenic component of the portal circulation, creation of a shunt for the portal blood into the systemic circulation, preservation of the splenic function and correction of the manifestations of the hypersplenism.
Introduction
The high morbidity and mortality of portal hypertension, due to oesophageal and gastric variceal haemorrhage, has resulted in a search for successful methods of intervention. [1] [2] [3] [4] [5] [6] [7] [8] [9] Besides the intensive investigation to find a drug to control the high pressure in the portal system, to date, the most acceptable treatment is still surgery for the prevention of variceal rupture by reducing hydrostatic pressure within the varices.9 Sclerotherapy is a good treatment for cases of acute variceal haemorrhage, in patients with high operative risk.10 However, the follow-up of this procedure shows higher recurrent bleeding and more oesophageal and gastric complications than surgery.' [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Two fundamental types of surgical approach have been described: those which interrupt the portal-variceal connection, 8,14,15 and those which reduce the portal blood flow and pressure through a systemic diversion or shunt. [1] [2] [3] [4] [5] [6] [7] 12, 16 (Figure 1 ). When haemostasis was assured, the remaining vascularized spleen was replaced in its normal position. The divided splenic vein was then anastomosed end-to-side to the left renal vein, using six-zeros mononylon thread (Figure 2) . The abdomen was closed.
Results and discussion
On the fourth postoperative day, a splenoportogram through the exteriorized gastroepiploic vein showed patency of the splenorenal anastomosis, and a portal vein pressure of 17cm of water, in both cases. Scintillation scanning revealed reduced splenic masses with normal filling. Ultrasonography showed retrocostal spleen and free communication between splenic and renal veins (Figure 3) . On the seventh postoperative day, the haematological examinations showed normal values, and both patients left the hospital in good condition. During the 4 years follow-up, the two patients did not present with any problem related with the disease or surgery.
The first reported segmental splenectomy performed in humans was done, in 1959, at the same hospital from which the present work is reported.18 Segmental splenectomy is preferable to total splenectomy because of the importance of the spleen to the reticuloendothelial and haematopoietic systems. Conservative splenic surgery is performed in the management of trauma and some haematological illnesses. 1 9 The rationale for splenectomy in portal hypertension is the effort to eliminate the pancytopenia, that may exacerbate the illness. Preserving the upper pole of the spleen, as suggested here, enables the surgeon to achieve the goals of total splenectomy while maintaining splenic immunological function. The interruption of the blood flow from the spleen to the portal vein reduces the blood volume and pressure in the portal system. The splenorenal shunt decompresses the portal system by creating a bypass into the low pressure systemic venous circulation (Figures 2, 3) .
Follow-up sonography has shown that splenic dimensions did not increase substantially in the late postoperative period. Sonography was also successful in demonstrating patency of the splenorenal anastomosis20 (Figure 3 ). Scintillation scanning in the postoperative period indicated normal splenic filling. 21 The method described herein continues to be studied carefully in order to establish its advantages in decreasing portal hypertension while maintaining a viable splenic remnant. Before any conclusion can be reached it is still necessary to confirm the preservation of splenic function and to assess the status of oesophageal varices. We also need to verify the constitutional sequelae following the portal-systemic shunt. A longer follow-up is also required to observe whether the splenic remnant will be enlarged or not by the portal disease.
